How does cardiovascular disease first present in women and men?

Circulation

Volumn 132, Issue 14, 2015, Pages 1320-1328

  George, Julie ^a   Rapsomaniki, Eleni ^b   Pujades Rodriguez, Mar ^a   Shah, Anoop Dinesh ^a   Denaxas, Spiros ^a   Herrett, Emily ^c   Smeeth, Liam ^c   Timmis, Adam ^d   Hemingway, Harry ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Worldwide Clinical Trials UK   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

aging; cardiovascular diseases; electronic health records; incidence; population; risk factors; sex

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; GROUPS BY AGE; HEART ARREST; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REGISTER; SEX DIFFERENCE; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; SUBARACHNOID HEMORRHAGE; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS; VERY ELDERLY; AGE; BLOOD; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; DIABETES MELLITUS; ELECTRONIC HEALTH RECORD; HORMONE SUBSTITUTION; INCIDENCE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; UNITED KINGDOM;

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; CONTRACEPTIVES, ORAL, HORMONAL; DIABETES MELLITUS; ELECTRONIC HEALTH RECORDS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; UNITED KINGDOM;

EID: 84943425229     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.013797     Document Type: Article

References (46)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013 127 e6 e245. doi: 10.1161/CIR.0b013e31828124ad.
2. Murphy NF, MacIntyre K, Capewell S, Stewart S, Pell J, Chalmers J, Redpath A, Frame S, Boyd J, McMurray JJ., Hospital discharge rates for suspected acute coronary syndromes between 1990 and 2000: population based analysis. BMJ 2004 328 1413 1414. doi: 10.1136/bmj.38111.650741.F7
3. Beaglehole R, Ebrahim S, Reddy S, Voûte J, Leeder S, Chronic Disease Action Group Prevention of chronic diseases: a call to action. Lancet 2007 370 2152 2157. doi: 10.1016/S0140-6736(07)61700-0
4. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration Age-specific relevance of usual blood pressure to vascular mortality: a meta-Analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 360 1903 1913. doi: 10.1016/S0140-6736(02)11911-8
5. Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, Keltai M, Diaz R, Rangarajan S, Yusuf S, INTERHEART Investigators Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008 29 932 940. doi: 10.1093/eurheartj/ehn018
6. Hyvärinen M, Qiao Q, Tuomilehto J, Söderberg S, Eliasson M, Stehouwer CD., The difference between acute coronary heart disease and ischaemic stroke risk with regard to gender and age in Finnish and Swedish populations. Int J Stroke 2010 5 152 156. doi: 10.1111/j.1747-4949.2010.00423.x.
7. Kappert K, Böhm M, Schmieder R, Schumacher H, Teo K, Yusuf S, Sleight P, Unger T, ONTARGET/TRANSCEND Investigators Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET). Circulation 2012 126 934 941. doi: 10.1161/CIRCULATIONAHA.111.086660
8. Blumenthal D, Tavenner M., The "meaningful use" regulation for electronic health records. N Engl J Med 2010 363 501 504. doi: 10.1056/NEJMp1006114
9. Gaziano JM., The evolution of population science: advent of the mega cohort. JAMA 2010 304 2288 2289. doi: 10.1001/jama.2010.1691
10. Pujades-Rodriguez M, George J, Shah AD, Rapsomaniki E, Denaxas S, West R, Smeeth L, Timmis A, Hemingway H., Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1937360 people in England: lifetime risks and implications for risk prediction. Int J Epidemiol 2015 44 129 141. doi: 10.1093/ije/dyu218
11. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, Williams B, Hingorani A, Hemingway H., Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet 2014 383 1899 1911. doi: 10.1016/S0140-6736(14)60685-1
12. Pujades-Rodriguez M, Timmis A, Stogiannis D, Rapsomaniki E, Denaxas S, Shah A, Feder G, Kivimaki M, Hemingway H., Socioeconomic deprivation and the incidence of 12 cardiovascular diseases in 1.9 million women and men: implications for risk prediction and prevention. PLoS One 2014 9 e104671. doi: 10.1371/journal.pone.0104671
13. Herrett E, Shah AD, Boggon R, Denaxas S, Smeeth L, van Staa T, Timmis A, Hemingway H., Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. BMJ 2013 346 f2350. doi: 10.1136/bmj.f2350
14. Denaxas SC, George J, Herrett E, Shah AD, Kalra D, Hingorani AD, Kivimaki M, Timmis AD, Smeeth L, Hemingway H., Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol 2012 41 1625 1638. doi: 10.1093/ije/dys188
15. Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, Deanfield J, Smeeth L, Timmis A, Hemingway H., Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol 2015 3 105 113. doi: 10.1016/S2213-8587(14)70219-0
16. Gallagher AM, Puri S, Staa TV., Linkage of the General Practice Research Database (GPRD) with other data sources. Pharmacoepidemiol Drug Saf 2011 S230 S364
17. Mathur R, Bhaskaran K, Chaturvedi N, Leon DA, vanStaa T, Grundy E, Smeeth L., Completeness and usability of ethnicity data in UK-based primary care and hospital databases. J Public Health (Oxf) 2014 36 684 692. doi: 10.1093/pubmed/fdt116
18. Lewis JD, Bilker WB, Weinstein RB, Strom BL., The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2005 14 443 451. doi: 10.1002/pds.1115
19. Thompson SG, Pyke SD, Hardy RJ., The design and analysis of paired cluster randomized trials: an application of meta-Analysis techniques. Stat Med 1997 16 2063 2079. doi: 10.1002/(SICI)1097-0258(19970930)
20. Harrell FE Jr, Lee KL, Mark DB., Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996 15 361 387. doi: 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4
21. Department of Health Cardiovascular Disease Outcomes Strategy: Improving outcomes for people at risk or with cardiovascular disease 2013. https://www.gov.uk/government/publications/improving-cardiovascular-disease-outcomes-strategy. Accessed September 19, 2014
22. Leening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, Heeringa J, Portegies ML, Hofman A, Ikram MA, Hunink MG, Franco OH, Stricker BH, Witteman JC, Roos-Hesselink JW., Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ 2014 349 g5992. doi: 10.1136/bmj.g5992
23. Rothwell PM, Coull AJ, Silver LE, Fairhead JF, Giles MF, Lovelock CE, Redgrave JN, Bull LM, Welch SJ, Cuthbertson FC, Binney LE, Gutnikov SA, Anslow P, Banning AP, Mant D, Mehta Z, Oxford Vascular Study Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005 366 1773 1783. doi: 10.1016/S0140-6736(05)67702-1
24. Baena-Díez JM, Vidal-Solsona M, Byram AO, González-Casafont I, Ledesma-Ulloa G, Martí-Sans N., The epidemiology of cardiovascular disease in primary care The Zona Franca Cohort study in Barcelona, Spain. Rev Esp Cardiol 2010 63 1261 1269
25. Canoui-Poitrine F, Luc G, Juhan-Vague I, Morange PE, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Ducimetiere P, Empana JP, PRIME Study Group Respective contribution of conventional risk factors and antihypertensive treatment to stable angina pectoris and acute coronary syndrome as the first presentation of coronary heart disease: the PRIME Study. Eur J Cardiovasc Prev Rehabil 2009 16 550 555. doi: 10.1097/HJR.0b013e32832c88d1
26. Glynn RJ, Rosner B., Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005 162 975 982. doi: 10.1093/aje/kwi309
27. Ducimetière P, Ruidavets JB, Montaye M, Haas B, Yarnell J, PRIME Study Group Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study. Int J Epidemiol 2001 30 1057 1062. doi: 10.1093/ije/30.5.1057
28. Social Exclusion Task Force Improving the Way We Meet the Primary Health Care Needs of the Socially Excluded 2010 London Cabinet Office
29. Manolio TA, Weis BK, Cowie CC, Hoover RN, Hudson K, Kramer BS, Berg C, Collins R, Ewart W, Gaziano JM, Hirschfeld S, Marcus PM, Masys D, McCarty CA, McLaughlin J, Patel AV, Peakman T, Pedersen NL, Schaefer C, Scott JA, Sprosen T, Walport M, Collins FS., New models for large prospective studies: is there a better way? Am J Epidemiol 2012 175 859 866. doi: 10.1093/aje/kwr453
30. Collins R., What makes UK Biobank special? Lancet 2012 379 1173 1174. doi: 10.1016/S0140-6736(12)60404-8
31. Risch N, Schaefer C., Kaiser Permanente Research Program on Genes, Environment and Health 2011. www.rpgeh.kaiser.org. Accessed September 19, 2014
32. National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease 2013 Washington, DC National Academies Press
33. Lauer MS., Time for a creative transformation of epidemiology in the United States. JAMA 2012 308 1804 1805. doi: 10.1001/jama.2012.14838
34. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ., Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010 69 4 14. doi: 10.1111/j.1365-2125.2009.03537.x.
35. Burns EM, Rigby E, Mamidanna R, Bottle A, Aylin P, Ziprin P, Faiz OD., Systematic review of discharge coding accuracy. J Public Health (Oxf) 2012 34 138 148. doi: 10.1093/pubmed/fdr054
36. Payne RA, Abel GA, Simpson CR., A retrospective cohort study assessing patient characteristics and the incidence of cardiovascular disease using linked routine primary and secondary care data. BMJ Open 2012 2 e000723. doi: 10.1136/bmjopen-2011-000723
37. Marma AK, Berry JD, Ning H, Persell SD, Lloyd-Jones DM., Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006. Circ Cardiovasc Qual Outcomes 2010 3 8 14. doi: 10.1161/CIRCOUTCOMES.109.869727
38. Hippisley-Cox J, Coupland C, Robson J, Brindle P., Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. BMJ 2010 341 c6624. doi: 10.1136/bmj.c6624
39. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Piña IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr, Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK., Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation 2011 123 1243 1262. doi: 10.1161/CIR.0b013e31820faaf8
40. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285 2486 2497. doi:10.1001/jama.285.19.2486
41. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P., Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007 335 136. doi: 10.1136/bmj.39261.471806.55
42. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PWF., 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 suppl 2 S49 S73
43. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003 362 1527 1535. doi: 10.1016/S0140-6736(03)14739-3
44. JBS3 Board Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart 2014 100 suppl) ii1 ii67
45. Aaronson KD, Cowger J., Heart failure prognostic models: why bother? Circ Heart Fail 2012 5 6 9. doi: 10.1161/CIRCHEARTFAILURE.111.965848
46. Hippisley-Cox J, Coupland C, Brindle P., Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study. BMJ 2013 346 f2573. doi: 10.1136/bmj.f2573